HDAC1 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
Comparison | Statistical significance |
Normal-vs-Primary | 4.13970002721697E-09 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Stage1 |
2.99210000109795E-08 |
Normal-vs-Stage2 |
4.839200E-04 |
Normal-vs-Stage3 |
1.86790000000769E-06 |
Normal-vs-Stage4 |
5.95460000000214E-05 |
Stage1-vs-Stage2 |
9.811600E-01 |
Stage1-vs-Stage3 |
4.927400E-01 |
Stage1-vs-Stage4 |
1.849640E-01 |
Stage2-vs-Stage3 |
6.506600E-01 |
Stage2-vs-Stage4 |
3.128600E-01 |
Stage3-vs-Stage4 |
3.839000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Caucasian |
4.81530004758923E-09 |
Normal-vs-AfricanAmerican |
1.66599999995576E-06 |
Normal-vs-Asian |
9.747700E-02 |
Caucasian-vs-AfricanAmerican |
7.023200E-01 |
Caucasian-vs-Asian |
3.582600E-01 |
AfricanAmerican-vs-Asian |
4.450600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Male |
7.93620724692801E-12 |
Normal-vs-Female |
1.325000E-03 |
Male-vs-Female |
1.479790E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
Descriptions |
Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Normal_Weight |
1.56262999999601E-05 |
Normal-vs-Extreme_Weight |
1.5052004087579E-10 |
Normal-vs-Obese |
1.56949999996492E-06 |
Normal-vs-Extreme_Obese |
2.175800E-04 |
Normal_Weight-vs-Extreme_Weight |
2.759400E-01 |
Normal_Weight-vs-Obese |
9.943200E-01 |
Normal_Weight-vs-Extreme_Obese |
4.704400E-01 |
Extreme_Weight-vs-Obese |
2.416600E-01 |
Extreme_Weight-vs-Extreme_Obese |
8.472800E-01 |
Obese-vs-Extreme_Obese |
4.753400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Age(21-40Yrs) |
1.500420E-02 |
Normal-vs-Age(41-60Yrs) |
4.9942000535097E-09 |
Normal-vs-Age(61-80Yrs) |
9.36139999963004E-08 |
Normal-vs-Age(81-100Yrs) |
4.22810000000329E-06 |
Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.884410E-01 |
Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.934770E-01 |
Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.363600E-02 |
Age(41-60Yrs)-vs-Age(61-80Yrs) |
6.095000E-01 |
Age(41-60Yrs)-vs-Age(81-100Yrs) |
4.106400E-02 |
Age(61-80Yrs)-vs-Age(81-100Yrs) |
1.432550E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-VS-Type1 PRCC |
4.4760000039723E-08 |
Normal-VS-Type2 PRCC |
4.64880023365311E-10 |
Normal-VS-KIRP CIMP |
6.595400E-03 |
Normal-VS-Unclassified PRCC |
4.87989999964356E-07 |
Type1 PRCC-VS-Type2 PRCC |
1.65130000007174E-07 |
Type1 PRCC-VS-KIRP CIMP |
7.362600E-01 |
Type1 PRCC-VS-Unclassified PRCC |
2.715600E-01 |
Type2 PRCC-VS-KIRP CIMP |
4.130200E-01 |
Type2 PRCC-VS-Unclassified PRCC |
1.039570E-02 |
KIRP CIMP-VS-Unclassified PRCC |
9.574400E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
pathologic_N descriptions |
N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-N0 |
1.41389999708252E-09 |
Normal-vs-N1 |
2.845000E-04 |
Normal-vs-N2 |
1.950170E-02 |
N0-vs-N1 |
2.546400E-01 |
N0-vs-N2 |
9.698600E-01 |
N1-vs-N2 |
6.461000E-01 |
|
|